Company Analysis

Silexion Therapeutics Corp (SLXN)

Nasdaq: SLXN · Biological Products, (No Diagnostic Substances) · Ramat Gan, IL · filing with the SEC since 2024
Grade4.3
◀ Past 2.3● Present 2.7▶ Future 6.8
3 est.

The company now

Silexion Therapeutics Corp is classed by the SEC under Biological Products, (No Diagnostic Substances) (industry code 2836), based in Ramat Gan, IL. In its latest annual figures on file, for the fiscal year ended 2025-12-31, it reported revenue of $155 thousand and a loss of $12 million (its filed statements).

From its filings and filed figures; the desk's account of it is not written yet.

The desk's written account, its read of the annual report, the record in brief and the split of the revenue are not on file for this company yet.

SI Assistanton SLXN · research, not advice